Search

256 Newsroom

Health

Reliable health reporting and useful public-health information.

STUDY: HIV injectable drug offers pregnant, lactating mothers 100% protection

SPECIAL REPORT | URN | A sub-study of the landmark clinical trial evaluating the safety and efficacy of the twice-yearly injectable HIV prevention drug, Lenacapavir, has found that it provides 100 percent protection against HIV infection among pregnant and breastfeeding women using it as pre-exposure prophylaxis (PrEP). The Phase 3 PURPOSE 1 trial results, published … The post STUDY: HIV injectable drug offers pregna

The Independent Uganda · 2 Aug 2026